Funded Projects

15 transnational research consortia are under negotiation to be funded under the umbrella of the NEURON JTC 2019 ‘Translational Biomarkers in Brain Disorders’. In total, 60 research groups from 13 countries collaborate in these projects. The total funding volume of the call amounts to about 12.1 M€.

Projects and partners are shown below. Please click on “summary” to download a brief project overview.

 

Acronym

Title

Coordinator (in bold) and Partners

Country

ALTRUISM

Altered Translation in Autism

 

summary (pdf, 80 KB)

Mihailovic (IT)

Italy

 

Bourgeron (FR)

France

 

Selbach (GER)

Germany

 

Schratt (CH)

Switzerland

 

Topisirovic (CA)

Canada

ANTaRES

Biomarkers of ANTidepressant RESponse : early indicators and novel targets.

 

summary (pdf, 89 KB)

Tzavara (FR)

France

 

BELZEAUX (FR)

France

 

Turecki (CA)

Canada

 

Martin Sanchez (ES)

Spain

 

Robledo (ES)

Spain

BIOMIGA

A multidisciplinary approach to the identification of BIOmarkers of MIGraine: a proof of concept study based on the stratification of responders CGRP monoclonal Antibodies

 

summary (pdf, 80 KB)

Tassorelli (IT)

Italy

 

Pozo Rosich (ES)

Spain

 

May (GER)

Germany

BioStress

Translational biomarkers of traumatic stress

 

summary (pdf, 78 KB)

Andero (SP)

Spain

 

Klengel (GER)

Germany

 

Cardoner (SP)

Spain

 

Sandi (CH)

Switzerland

EBio2

Early mechanistic BIOmarkers for late Epilepsy and long-term Brain Injury Outcome

 

summary (pdf, 78 KB)

Dreier (GER)

Germany

 

Friedman (CA)

Canada

 

Vezzani (IT)

Italy

GEPI-BIOPSY

Genomic, epigenetic and proteomic biomarkers in psychosis: a translational approach including high-risk individuals, patients with schizophrenia and animal models

 

summary (pdf, 78 KB)

Labad (ES)

Spain

 

Krebs (FR)

France

 

Schulze (GER)

Germany

GUT2BEHAVE

Metabolic profiling of the gut-brain axis as a new stratification process to improve behavioural disorders: proof of concept in alcohol dependence.

 

summary (pdf, 88 KB)

Delzenne (BE)

Belgium

 

Hanhineva (FI)

Finland

 

Layé (FR)

France

iBioStroke

Identification and clinical validation of biomarkers for long-term outcome after cerebral ischemia

 

summary (pdf, 79 KB)

Popa-Wagner (RO)

Romania

 

Plesnila (GER)

Germany

 

Malm (FI)

Finland

 

Fernández Cadenas (ES)

Spain

 

Slowik (PL)

Poland

IMBALANCE

A neurocomputational biomarker assay for schizophrenia based on E/I-balance

 

summary (pdf, 81 KB)

Sterzer (GER)

Germany

 

Donner (GER)

Germany

 

de la Rocha (ES)

Spain

 

Ostojic (FR)

France

 

Peter (UK*)

UK

MOODMARKER

Discovery, verification and validation of a biomarker profile for depression

 

summary (pdf, 79 KB)

Mechawar (CA)

Canada

 

Cattane (IT)

Italy

 

Otto (GER)

Germany

 

Pryce (CH)

Switzerland

Muliobio

Multi-level integrative ‘omics to identify biomarkers in a Schizophrenia and other major psychoses

 

summary (pdf, 79 KB)

Poschmann (FR)

France

 

Schulze (GER)

Germany

 

Jurisica (CA)

Canada

NeuroMarKet

Neuroimaging and Blood Biomarkers as Indicators of Ketamine Efficacy in Treatment Resistent Depression

 

summary (pdf, 79 KB)

Walter (GER)

Germany

 

Lecourtier (FR)

France

 

Coffey (FI)

Finland

 

Sartorius (GER)

Germany

Neu-vasc

Neurovascular damage determines disease pathophysiology in pediatric mild traumatic brain injury: source of new biomarkers

 

summary (pdf, 122 KB)

Badaut (FR)

France

 

Marchi (FR)

France

 

Koerte (GER)

Germany

 

Thompson (CA)

Canada

 

Filipcik (SK)

Slovakia

NicAb

Novel biomarkers in neurological and psychiatric disorders: autoantibodies to neuronal nicotinic acetylcholine receptors

 

summary (pdf, 79 KB)

Tzartos (GR)

Greece

 

Mantegazza (IT)

Italy

 

Steiner (GER)

Germany

STATEMENT

Stroke risk prediction in atherosclerosis measuring circulating complement system proteins

 

summary (pdf, 79 KB)

Fumagalli (IT)

Italy

 

Montecucco (IT)

Italy

 

Mollnes (NO)

Norway

 

Canet Soulas (FR)

France

 

Manduteanu (RO)

Romania


top